Render Target: STATIC
Render Timestamp: 2024-11-28T12:20:36.841Z
Commit: d79925545b26f8827f92d145dadc6f0527debdb1
XML generation date: 2024-11-18 16:03:11.776
Product last modified at: 2024-11-19T09:00:37.083Z
1% for the planet logo
PDP - Template Name: Monoclonal Antibody
PDP - Template ID: *******c5e4b77
R Recombinant
Recombinant: Superior lot-to-lot consistency, continuous supply, and animal-free manufacturing.

EXOSC2 (F6Y3J) Rabbit mAb #23542

Filter:
  • WB
  • IP

    Supporting Data

    REACTIVITY H Mk
    SENSITIVITY Endogenous
    MW (kDa) 29
    Source/Isotype Rabbit IgG
    Application Key:
    • WB-Western Blotting 
    • IP-Immunoprecipitation 
    Species Cross-Reactivity Key:
    • H-Human 
    • Mk-Monkey 

    Product Information

    Product Usage Information

    Application Dilution
    Western Blotting 1:1000
    Immunoprecipitation 1:50

    Storage

    Supplied in 10 mM sodium HEPES (pH 7.5), 150 mM NaCl, 100 µg/mL BSA, 50% glycerol, and less than 0.02% sodium azide. Store at –20°C. Do not aliquot the antibody.

    Protocol

    Specificity / Sensitivity

    EXOSC2 (F6Y3J) Rabbit mAb recognizes endogenous levels of total EXOSC2 protein. This antibody detects a 90 kDa protein of unknown origin.

    Species Reactivity:

    Human, Monkey

    Source / Purification

    Monoclonal antibody is produced by immunizing animals with a synthetic peptide corresponding to residues surrounding Leu14 of human EXOSC2 protein.

    Background

    Exosome component 2 (EXOSC2), also known as RRP4, is part of the exosome complex involved in RNA processing and mRNA decay by utilizing 3’-5’ exoribonuclease activity (1,2). The exosome consists of an inert ring of nine subunits coupled with the enzyme DIS3 or DIS3L (3-5). EXOSC2, along with EXOSC1 and EXOSC3, forms the cap of the complex and assists in 5.8S rRNA generation and mRNA degradation (1,6). Missense mutations in EXOSC2 alter exosome binding to certain mRNAs and cause a syndrome termed SHRF (short stature, hearing loss, retinitis pigmentosa, and distinctive facies) (7,8). Overexpression of EXOSC2 was shown to promote metastatic breast cancer in a tRNA-dependent manner (9).
    For Research Use Only. Not For Use In Diagnostic Procedures.
    Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
    All other trademarks are the property of their respective owners. Visit our Trademark Information page.